An overview of the
current data from PsoProtectMe

Current Data

We are committed to sharing data and are delighted to provide open access to summary information from PsoProtectMe. These data are preliminary and include a limited number of participants, so should not be used to inform clinical decision making.

PsoProtectMe surveys completed

Summary data from PsoProtectMe’s first 1000 participants.

Participants per continent (total 39 countries):

Continent Participants
Europe 839
South America 71
Asia 62
North America 17
Australia 6
Africa 5

Average age: 33 years (range 11-91)

Average BMI: 21 kg/m2

Type of psoriasis: 860 plaque psoriasis, 241 guttate psoriasis, 46 pustular psoriasis, 18 erythrodema


Smoking status:

Coexisting psoriatic arthritis:

Type of psoriasis treatment:

Psoriasis severity change during the pandemic:

Have you been diagnosed with or thought you had COVID-19?

Did you go to hospital A&E due to your COVID-19?

Did you stay in hospital due to your COVID-19?

Has your COVID-19 infection got better?